Cargando…
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those fo...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828830/ https://www.ncbi.nlm.nih.gov/pubmed/27067270 http://dx.doi.org/10.1186/s13075-016-0982-5 |
_version_ | 1782426659172909056 |
---|---|
author | Bartlett, David B. Connelly, Margery A. AbouAssi, Hiba Bateman, Lori A. Tune, K. Noelle Huebner, Janet L. Kraus, Virginia B. Winegar, Deborah A. Otvos, James D. Kraus, William E. Huffman, Kim M. |
author_facet | Bartlett, David B. Connelly, Margery A. AbouAssi, Hiba Bateman, Lori A. Tune, K. Noelle Huebner, Janet L. Kraus, Virginia B. Winegar, Deborah A. Otvos, James D. Kraus, William E. Huffman, Kim M. |
author_sort | Bartlett, David B. |
collection | PubMed |
description | BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those for persons without RA. METHODS: Plasma GlycA was determined for 50 individuals with mild-moderate RA disease activity and 39 controls matched for age, gender, and body mass index (BMI). Regression analyses were performed to assess relationships between GlycA and important markers of traditional inflammation and cardio-metabolic health: inflammatory cytokines, disease activity, measures of adiposity and insulin resistance. RESULTS: On average, RA activity was low (DAS-28 = 3.0 ± 1.4). Traditional inflammatory markers, ESR, hsCRP, IL-1β, IL-6, IL-18 and TNF-α were greater in RA versus controls (P < 0.05 for all). GlycA concentrations were significantly elevated in RA versus controls (P = 0.036). In RA, greater GlycA associated with disease activity (DAS-28; R(DAS-28) = 0.5) and inflammation (R(ESR) = 0.7, R(hsCRP) = 0.7, R(IL-6) = 0.3: P < 0.05 for all); in BMI-matched controls, these inflammatory associations were absent or weaker (hsCRP), but GlycA was related to IL-18 (R(hsCRP) = 0.3, R(IL-18) = 0.4: P < 0.05). In RA, greater GlycA associated with more total abdominal adiposity and less muscle density (R(abdominal-adiposity) = 0.3, R(muscle-density) = −0.3, P < 0.05 for both). In BMI-matched controls, GlycA associated with more cardio-metabolic markers: BMI, waist circumference, adiposity measures and insulin resistance (R = 0.3-0.6, P < 0.05 for all). CONCLUSIONS: GlycA provides an integrated measure of inflammation with contributions from traditional inflammatory markers and cardio-metabolic sources, dominated by inflammatory markers in persons with RA and cardio-metabolic factors in those without. |
format | Online Article Text |
id | pubmed-4828830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48288302016-04-13 A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls Bartlett, David B. Connelly, Margery A. AbouAssi, Hiba Bateman, Lori A. Tune, K. Noelle Huebner, Janet L. Kraus, Virginia B. Winegar, Deborah A. Otvos, James D. Kraus, William E. Huffman, Kim M. Arthritis Res Ther Research Article BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those for persons without RA. METHODS: Plasma GlycA was determined for 50 individuals with mild-moderate RA disease activity and 39 controls matched for age, gender, and body mass index (BMI). Regression analyses were performed to assess relationships between GlycA and important markers of traditional inflammation and cardio-metabolic health: inflammatory cytokines, disease activity, measures of adiposity and insulin resistance. RESULTS: On average, RA activity was low (DAS-28 = 3.0 ± 1.4). Traditional inflammatory markers, ESR, hsCRP, IL-1β, IL-6, IL-18 and TNF-α were greater in RA versus controls (P < 0.05 for all). GlycA concentrations were significantly elevated in RA versus controls (P = 0.036). In RA, greater GlycA associated with disease activity (DAS-28; R(DAS-28) = 0.5) and inflammation (R(ESR) = 0.7, R(hsCRP) = 0.7, R(IL-6) = 0.3: P < 0.05 for all); in BMI-matched controls, these inflammatory associations were absent or weaker (hsCRP), but GlycA was related to IL-18 (R(hsCRP) = 0.3, R(IL-18) = 0.4: P < 0.05). In RA, greater GlycA associated with more total abdominal adiposity and less muscle density (R(abdominal-adiposity) = 0.3, R(muscle-density) = −0.3, P < 0.05 for both). In BMI-matched controls, GlycA associated with more cardio-metabolic markers: BMI, waist circumference, adiposity measures and insulin resistance (R = 0.3-0.6, P < 0.05 for all). CONCLUSIONS: GlycA provides an integrated measure of inflammation with contributions from traditional inflammatory markers and cardio-metabolic sources, dominated by inflammatory markers in persons with RA and cardio-metabolic factors in those without. BioMed Central 2016-04-12 2016 /pmc/articles/PMC4828830/ /pubmed/27067270 http://dx.doi.org/10.1186/s13075-016-0982-5 Text en © Bartlett et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Bartlett, David B. Connelly, Margery A. AbouAssi, Hiba Bateman, Lori A. Tune, K. Noelle Huebner, Janet L. Kraus, Virginia B. Winegar, Deborah A. Otvos, James D. Kraus, William E. Huffman, Kim M. A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls |
title | A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls |
title_full | A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls |
title_fullStr | A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls |
title_full_unstemmed | A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls |
title_short | A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls |
title_sort | novel inflammatory biomarker, glyca, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in bmi-matched controls |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828830/ https://www.ncbi.nlm.nih.gov/pubmed/27067270 http://dx.doi.org/10.1186/s13075-016-0982-5 |
work_keys_str_mv | AT bartlettdavidb anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT connellymargerya anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT abouassihiba anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT batemanloria anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT tuneknoelle anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT huebnerjanetl anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT krausvirginiab anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT winegardeboraha anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT otvosjamesd anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT krauswilliame anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT huffmankimm anovelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT bartlettdavidb novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT connellymargerya novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT abouassihiba novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT batemanloria novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT tuneknoelle novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT huebnerjanetl novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT krausvirginiab novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT winegardeboraha novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT otvosjamesd novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT krauswilliame novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols AT huffmankimm novelinflammatorybiomarkerglycaassociateswithdiseaseactivityinrheumatoidarthritisandcardiometabolicriskinbmimatchedcontrols |